Background and Aims: Chronic intestinal pseudo-obstruction (CIPO) is an intractable disease in which clinical symptoms of intestinal obstruction appear without mechanical cause. No clear diagnostic criteria have been established; therefore, we proposed diagnostic criteria to facilitate the diagnosis of this rare disease and aim to evaluate their usefulness and validity. Materials andMethods: A questionnaire was sent to 378 institutions belonging to the Japanese Society of Gastroenterology between December 2009 and February 2010. We summarized the returned data and performed a statistical analysis. Results: A total of 160 cases were included, and 141 cases (88.1%) fulfilled the criterion of disease duration of >6 months, 157 cases (98.1%) the criterion of the clinical symptoms of abdominal pain and/or bloating and 154 cases (96.2%) fulfilled the criterion of imaging findings. Eventually, 138 cases (86.3%) fulfilled all criteria. Conclusions: The proposed diagnostic criteria were useful, with a high sensitivity of 86.3% for Japanese patients. Improved recognition of CIPO and practical use of the criteria are desired. The criteria should be appropriately modified by additional researchers to make them more practical and internationally applicable.

Journal Section:
Original Paper
Keywords:
Chronic intestinal pseudo-obstruction, Diagnostic criteria, Algorithm
1.
Dudley HA, Sinclair IS, McLaren IF, McNair TJ, Newsam JE: Intestinal pseudo-obstruction. J R Coll Surg Edinb 1958;3:206–217.
2.
Manten HD: Pseudo-obstruction; in Haubrich WS, Schaffner F, Berk JE (eds): Bockus Gastroenterology, ed 5. Philadelphia, Saunders, 1995, pp 1249–1267.
3.
Sutton DH, Harrell SP, Wo JM: Diagnosis and management of adult patients with chronic intestinal pseudoobstruction. Nutr Clin Pract 2006;21:16–22.
[PubMed]
https://doi.org/10.1177%2F011542650602100116
4.
Anras S: The colon in the pseudo-obstructive syndrome. Clin Gastroenterol 1986;15:745–762.
5.
Connor FL, Di Lorenzo C: Chronic intestinal pseudo-obstruction: assessment and management. Gastroenterology 2006;130: S29–S36.
https://doi.org/10.1053%2Fj.gastro.2005.06.081
6.
Nakajima Group Research Report, Fiscal Year 2009 (chief investigator: Atsushi Nakajima). Research Group for the Survey of the Actual Conditions of the Epidemiology, Diagnosis and Treatment of CIIP in Japan. Research Project for Overcoming Intractable Diseases, Health Labour Sciences Research Grant. Yokohama, Sanou Printing Ltd, 2010, pp 1–42.
7.
Rudolph CD, Hyman PE, Altschuler SM, Christensen J, Colletti RB, Cucchiara S, Di Lorenzo C, Flores AF, Hillemeier AC, McCallum RW, Vanderhoof JA: Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr 1997;24:102–112.
[PubMed]
https://doi.org/10.1097%2F00005176-199701000-00021
8.
Iida H, Inamori M, Sekino Y, Sakamoto Y, Yamato S, Nakajima A: A review of the reported cases of chronic intestinal pseudo-obstruction in Japan and an investigation of proposed new diagnostic criteria. Clin J Gastroenterol 2011;4:141–146.
https://doi.org/10.1007%2Fs12328-011-0219-8
9.
Stanghellini V, Cogliandro RF, De Giorgio R, Barbara G, Cremon C, Antonucci A, Fronzoni L, Cogliandro L, Naponelli V, Serra M, Corinaldesi R: Natural history of intestinal failure induced by chronic idiopathic intestinal pseudo-obstruction. Transplant Proc 2010;42:15–18.
https://doi.org/10.1016%2Fj.transproceed.2009.12.017
10.
Di Lorenzo C: Pseudo-obstruction: current approaches. Gastroenterology 1999;116:980–987.
https://doi.org/10.1016%2FS0016-5085%2899%2970082-X
11.
Lacy BE: Chronic intestinal pseudo-obstruction. The Association of Gastrointestinal Motility Disorders, Inc. (AGMD). http://www.agmd-gimotility.org/lacycip.pdf.
12.
Amiot A, Cazals-Hatem D, Joly F, Lavergne-Slove A, Peuchmaur M, Bouhnik Y, Bedossa P, Messing B: The role of immunohistochemistry in idiopathic chronic intestinal pseudoobstruction (CIPO): a case-control study. Am J Surg Pathol 2009;33:749–758.
https://doi.org/10.1097%2FPAS.0b013e31819b381a
13.
De Giorgio R, Sarnelli G, Corinaldesi R, Stanghellini V: Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut 2004;53:1549–1552.
https://doi.org/10.1136%2Fgut.2004.043968
14.
Moore SW, Schneider JW, Kaschula RO: Unusual variations of gastrointestinal smooth muscle abnormalities associated with chronic intestinal pseudo-obstruction. Pediatr Surg Int 2002;18:13–20.
https://doi.org/10.1007%2Fs003830200003
© 2012 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2012
You do not currently have access to this content.